BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 28238064)

  • 1. Hepatic inflammation-fibrosis-cancer axis in the rat hepatocellular carcinoma induced by diethylnitrosamine.
    Ding YF; Wu ZH; Wei YJ; Shu L; Peng YR
    J Cancer Res Clin Oncol; 2017 May; 143(5):821-834. PubMed ID: 28238064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma.
    Duan XY; Pan Q; Yan SY; Ding WJ; Fan JG; Qiao L
    BMC Gastroenterol; 2014 Nov; 14():195. PubMed ID: 25410681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baishouwu Extract Suppresses the Development of Hepatocellular Carcinoma via TLR4/MyD88/NF-κB Pathway.
    Ding YF; Peng ZX; Ding L; Peng YR
    Front Pharmacol; 2019; 10():389. PubMed ID: 31068809
    [No Abstract]   [Full Text] [Related]  

  • 4. [Influence of bear bile on rat hepatocarcinoma induced by diethylnitrosamine].
    Zhou JY; Yin ZY; Wang SY; Yan JH; Zhao YL; Wu D; Liu ZJ; Zhang S; Wang XM
    Yao Xue Xue Bao; 2012 Nov; 47(11):1483-8. PubMed ID: 23387081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardization of diethylnitrosamine-induced hepatocellular carcinoma rat model with time based molecular assessment.
    Ghufran H; Azam M; Mehmood A; Butt H; Riazuddin S
    Exp Mol Pathol; 2021 Dec; 123():104715. PubMed ID: 34699901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of Steamed and Freeze-Dried Mature Silkworm Larval Powder Prevents Hepatic Fibrosis and Hepatocellular Carcinogenesis by Blocking TGF-β/STAT3 Signaling Cascades in Rats.
    Lee DY; Yun SM; Song MY; Ji SD; Son JG; Kim EH
    Cells; 2020 Feb; 9(3):. PubMed ID: 32121064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Branched-chain amino acids ameliorate fibrosis and suppress tumor growth in a rat model of hepatocellular carcinoma with liver cirrhosis.
    Cha JH; Bae SH; Kim HL; Park NR; Choi ES; Jung ES; Choi JY; Yoon SK
    PLoS One; 2013; 8(11):e77899. PubMed ID: 24223741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The DEN and CCl4 -Induced Mouse Model of Fibrosis and Inflammation-Associated Hepatocellular Carcinoma.
    Uehara T; Pogribny IP; Rusyn I
    Curr Protoc Pharmacol; 2014 Sep; 66():14.30.1-14.30.10. PubMed ID: 25181010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and differentiation of early hepatocellular carcinoma from cirrhosis using CT perfusion in a rat liver model.
    Li JP; Feng GL; Li DQ; Wang HB; Zhao DL; Wan Y; Jiang HJ
    Hepatobiliary Pancreat Dis Int; 2016 Dec; 15(6):612-618. PubMed ID: 27919850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compound Astragalus and Salvia miltiorrhiza extract suppresses hepatocellular carcinoma progression by inhibiting fibrosis and PAI-1 mRNA transcription.
    Rui W; Xie L; Liu X; He S; Wu C; Zhang X; Zhang L; Yang Y
    J Ethnopharmacol; 2014; 151(1):198-209. PubMed ID: 24247078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in rat models with hepatocellular carcinoma with liver cirrhosis.
    Park SI; Lee JH; Ham HJ; Jung YJ; Park MS; Lee J; Maeng LS; Chung YA; Jang KS
    Biomed Mater Eng; 2015; 26 Suppl 1():S1669-76. PubMed ID: 26405933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asarone and metformin delays experimentally induced hepatocellular carcinoma in diabetic milieu.
    Das BK; Choukimath SM; Gadad PC
    Life Sci; 2019 Aug; 230():10-18. PubMed ID: 31121175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective Effects of Ethyl Acetate Soluble Fraction of Limonium tetragonum on Diethylnitrosamine-Induced Liver Fibrosis in Rats.
    Kim NH; Heo JD; Kim TB; Rho JR; Yang MH; Jeong EJ
    Biol Pharm Bull; 2016; 39(6):1022-8. PubMed ID: 27251505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential changes in hepatocarcinogenesis induced by diethylnitrosamine plus thioacetamide in Fischer 344 rats: induction of gankyrin expression in liver fibrosis, pRB degradation in cirrhosis, and methylation of p16(INK4A) exon 1 in hepatocellular carcinoma.
    Park TJ; Kim HS; Byun KH; Jang JJ; Lee YS; Lim IK
    Mol Carcinog; 2001 Mar; 30(3):138-50. PubMed ID: 11301474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of ErbB receptor proteins and TGF-alpha during diethylnitrosamine-induced hepatocarcinogenesis in the rat liver.
    Lee TY; Kim KT; Han SY
    Korean J Hepatol; 2007 Mar; 13(1):70-80. PubMed ID: 17380077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult mouse model of early hepatocellular carcinoma promoted by alcoholic liver disease.
    Ambade A; Satishchandran A; Gyongyosi B; Lowe P; Szabo G
    World J Gastroenterol; 2016 Apr; 22(16):4091-108. PubMed ID: 27122661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR4 Deficiency Protects against Hepatic Fibrosis and Diethylnitrosamine-Induced Pre-Carcinogenic Liver Injury in Fibrotic Liver.
    Weber SN; Bohner A; Dapito DH; Schwabe RF; Lammert F
    PLoS One; 2016; 11(7):e0158819. PubMed ID: 27391331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development.
    Wu K; Ding J; Chen C; Sun W; Ning BF; Wen W; Huang L; Han T; Yang W; Wang C; Li Z; Wu MC; Feng GS; Xie WF; Wang HY
    Hepatology; 2012 Dec; 56(6):2255-67. PubMed ID: 22898879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Therapeutic Effect of Myrrh (Commiphora molmol) and Doxorubicin on Diethylnitrosamine Induced Hepatocarcinogenesis in Male Albino Rats.
    Anwar HM; Moghazy AM; Osman AAE; Abdel Rahman AAS
    Asian Pac J Cancer Prev; 2021 Jul; 22(7):2153-2163. PubMed ID: 34319038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic administration of diethylnitrosamine to induce hepatocarcinogenesis and to evaluate its synergistic effect with other hepatotoxins in mice.
    Fuentes-Hernández S; Alarcón-Sánchez BR; Guerrero-Escalera D; Montes-Aparicio AV; Castro-Gil MP; Idelfonso-García OG; Rosas-Madrigal S; Aparicio-Bautista DI; Pérez-Hernández JL; Reyes-Gordillo K; Lakshman MR; Vásquez-Garzón VR; Baltiérrez-Hoyos R; López-González ML; Sierra-Santoyo A; Villa-Treviño S; Pérez-Carreón JI; Arellanes-Robledo J
    Toxicol Appl Pharmacol; 2019 Sep; 378():114611. PubMed ID: 31176654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.